Inozyme Pharma Inc.

1.41
-0.11 (-7.24%)
At close: Jan 29, 2025, 3:59 PM
1.42
0.71%
After-hours Jan 29, 2025, 07:55 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY01
PE Ratio -3.1 -0.61 -2.85 -8.64 -14.28 -38.13 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 1.57 0.33 1.47 3.05 -8 -19.14 n/a
P/FCF Ratio -3.11 -0.68 -3.31 -13.21 -14.03 -27.38 n/a
P/OCF Ratio -3.12 -0.69 -3.34 -13.42 -14.14 -28.13 n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.33 0.06 0.03 0.01 n/a n/a n/a
Quick Ratio 13.36 8.94 9.92 16.38 14.67 18.11 n/a
Current Ratio 13.36 8.93 9.92 15.14 14.67 18.11 n/a
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -22.7 n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.51 -0.55 -0.52 -0.35 0.56 0.50 n/a
Return on Assets (ROA) -0.35 -0.47 -0.46 -0.33 -0.39 -0.16 n/a
Return on Capital (ROIC) -0.41 -0.55 -0.51 -0.36 -0.47 -0.28 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a